Serum sickness-like reaction and bupropion.
Waibel
Kirk H
KH
Katial
Rohit K
RK
D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy; D016642:Bupropion / Q000009:adverse effects* / Q000627:therapeutic use; D018765:Dopamine Uptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008776:Methylprednisolone Hemisuccinate / Q000627:therapeutic use; D012713:Serum Sickness / Q000139:chemically induced* / Q000188:drug therapy
D000893:Anti-Inflammatory Agents; D018765:Dopamine Uptake Inhibitors; D016642:Bupropion; D008776:Methylprednisolone Hemisuccinate